Debt Burden Makes Horizon Pharma An Attractive Short [View article]
Currently, there are four firms covering Horizon. Stifel Nicolaus carries a price target of $10 on Horizon, while JMP has a target of $16. The targets represent upside of 31 percent and 110 percent from today's price in the $7.50 to $7.60 range, respectively.
Debt Burden Makes Horizon Pharma An Attractive Short [View article]
Debt Burden Makes Horizon Pharma An Attractive Short [View article]
Debt Burden Makes Horizon Pharma An Attractive Short [View article]
http://seekingalpha.co...
Debt Burden Makes Horizon Pharma An Attractive Short [View article]
Buy Codexis For Its Growing Pharma Business [View article]